![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1099-1069|33|S1|46-49
ISSN: 0278-0232
Source: Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 46-49
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Directions in the Diagnosis and Treatment of Chronic Lymphocytic Leukaemia
Drugs, Vol. 63, Iss. 10, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of Chronic Lymphocytic Leukaemia
Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fludarabine in chronic lymphocytic leukaemia
By Elter Thomas Hallek Michael Engert Andreas
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Singer Charles Goldstone Tony
Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. :